Acupuncture for the prevention of radiation-induced xerostomia in patients with head and neck cancer by BRAGA, Fabio do Prado Florence et al.
Stomatology
180 Braz Oral Res. 2011 Mar-Apr;25(2):180-5
Fabio do Prado Florence Braga(a)
Celso Augusto Lemos Junior(a)
Fabio Abreu Alves(a)
Dante Antonio Migliari(a)
 (a) Department of Stomatology, School of 
Dentistry, University of São Paulo, São 
Paulo, SP, Brazil.
Stomatology
Corresponding author 
Fabio do Prado Florence Braga 
Universidade de São Paulo, Faculdade de  
 Odontologia, Departamento de  
 Estomatologia, Disciplina de Estomatologia 
 Clínica 
Avenida Professor Lineu Prestes, 2227,  
 Cidade Universitária 
São Paulo - SP - Brazil 
CEP: 05508-900 
E-mail: fbraga@usp.br
Received for publication on Aug 24, 2010 
Accepted for publication on Jan 11, 2011
Acupuncture for the prevention of 
radiation-induced xerostomia in 
patients with head and neck cancer
Abstract: The aim of this study was to evaluate the effectiveness of acu-
puncture in minimizing the severity of radiation-induced xerostomia in 
patients with head and neck cancer. A total of 24 consecutive patients re-
ceiving > 5000 cGy radiotherapy (RT) involving the major salivary glands 
bilaterally were assigned to either the preventive acupuncture group (PA, 
n = 12), treated with acupuncture before and during RT, or the control 
group (CT, n = 12), treated with RT and not receiving acupuncture. After 
RT completion, clinical response was assessed in all patients by syalom-
etry, measuring the resting (RSFR) and stimulated (SSFR) salivary flow 
rates, and by the visual analogue scale (VAS) regarding dry mouth-related 
symptoms. Statistical analyses were performed with repeated-measures 
using a mixed-effect modeling procedure and analysis of variance. An 
alpha level of 0.05 was accepted for statistical significance. Although all 
patients exhibited some degree of impairment in salivary gland function-
ing after RT, significant differences were found between the groups. Pa-
tients in the PA group showed improved salivary flow rates (RSFR, SSFR; 
p < 0.001) and decreased xerostomia-related symptoms (VAS, p < 0.05) 
compared with patients in the CT group. Although PA treatment did not 
prevent the oral sequelae of RT completely, it significantly minimized the 
severity of radiation-induced xerostomia. The results suggest that acu-
puncture focused in a preventive approach can be a useful therapy in the 
management of patients with head and neck cancer undergoing RT.
Descriptors: Acupuncture; Radiotherapy; Xerostomia.
Introduction
Xerostomia (dry mouth) is the most frequent and potentially debilitat-
ing side-effect of radiotherapy (RT) for head and neck cancer. Xerosto-
mia can result in long-term or even permanent oral function impairment 
and usually is associated with morbidity that profoundly affects the qual-
ity of life.1-4 Several potential methods for preventing radiation-induced 
xerostomia have been described; however, xerostomia management is 
complex and often is refractory to most interventions.5
Studies using systemic sialogogues (e.g., pilocarpine) concomitant 
with RT have failed to show significant maintenance of saliva produc-
tion. Moreover, these therapies have the potential to induce a wide range 
of unfavorable side effects.6 Surgical submandibular salivary gland trans-
fer to the submental space outside of the radiation field appears to be 
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promising; however, there are specific restrictions 
on its indication and the technique is not available 
readily in oncology centers.7 The cytoprotective 
agent amifostine combined with careful treatment 
planning, including intensity-modulated radiation 
therapy (IMRT), can minimize radiation-induced 
xerostomia; however, this drug is associated with 
unfavorable side effects and IMRT is not available 
in many oncology centers.8-10
Despite the benefits of the above methods, all 
treatments have met with limited success. For many 
patients, only palliative care remains, in the form 
of a wide variety of salivary substitutes or simple 
water consumption, providing merely dry mouth 
symptomatic relief. These considerations lead many 
patients to search for alternative or complementary 
treatment methods, including acupuncture. As a 
therapeutic method, acupuncture involves the inser-
tion of tiny needles at specific points, with the intent 
to prevent or cure diseases and symptoms and there-
by to reestablish health.11 The use of acupuncture 
for xerostomia first appeared in the Western medical 
literature in 1981.12 Acupuncture administered after 
RT in the management of patients with xerostomia 
was investigated in early studies, demonstrating the 
benefits of this therapy for improving salivary flow 
rates and reducing xerostomia-related symptoms.13-18
However, studies of acupuncture use in xero-
stomia have focused mainly on a curative approach 
when the salivary gland tissues are already damaged 
and xerostomia is present. To our knowledge, no 
study has addressed the use of acupuncture for the 
prevention of irradiation-induced xerostomia. Ac-
cordingly, the aim of this study was to investigate 
the effectiveness of preventive acupuncture (PA) 
treatment in minimizing irradiation side effects on 
salivary flow rates and xerostomia-related symp-
toms in patients with head and neck cancer under-
going RT.
Materials and methods
Patients
A total of 24 eligible patients (8 females, 16 males; 
age range 44-82 years; mean age 63 years) with head 
and neck cancer (squamous cell carcinoma) were 
included. Patients were receiving either primary or 
postoperative external beam RT ( > 5000 cGy) whose 
irradiation fields involved ≥ 50% of the major sali-
vary gland volume. Patients who received concomi-
tant chemotherapy were not excluded. This study 
was approved by the Research Ethics Committees of 
the School of Dentistry, University of São Paulo and 
the Brazilian Institute for Cancer Control, Brazil.
Study design
The 24 subjects enrolled in this study were di-
vided into 2 groups. The preventive acupuncture 
group (PA group) was comprised of 12 consecutive 
patients (3 females, 9 males; age range 47-82 years; 
mean age 64.5 years) who received acupuncture be-
fore and during the entire period of RT. The control 
group (CT group) was comprised of 12 consecutive 
patients (5 females, 7 males; age range 44-72 years; 
mean age 58 years) who were treated with RT and 
did not receive acupuncture or any other therapeutic 
modality to minimize the irradiation side effects.
After providing written informed consent, all 
patients were submitted to a clinical examination. 
Data regarding their treatment profiles, including 
RT, chemotherapy, and surgical planning, were 
gathered by a chart review. Data are summarized in 
Tables 1 and 2.
The RT planning for all patients included 33-35 
sessions administered in fractional daily doses of 
180-200 cGy, 5 days a week, with a linear accelera-
tor (6-MV photons) or a TeleCobalt 60 unit. The 
mean total dose administered was 6,770 cGy (range 
6,040-7,500 cGy) in the PA group and 6,810 cGy 
(range 6,040-7,580 cGy) in the CT group. The PA 
protocol was administered in the PA group before 
and during RT, twice a week, for 16-20 sessions. 
The protocol was conducted by the same clinician 
(FPFB), who was certified in acupuncture.
Acupuncture protocol
Acupuncture points (acupoints) were selected ac-
cording to the principles of traditional Chinese and 
orthodox Western medicine. Local (ST-3, ST-4, ST-
5, ST-6, ST-7, GB-2, SI-19, TB-21), distal (LI-4, LI-
11, LR-3, ST-36, KI-3, KI-5, GV-20), and auricular 
(Shen-Men, Central Nervous System, Neurovegeta-
tive System, Kidney, Spleen, Pancreas, and Mouth) 
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acupoints, named in accordance with the WHO 
Standard Acupuncture Nomenclature,19 were in-
cluded. For each patient, every acupoint was used in 
all treatment sessions for a total of 29 punctures (14 
bilaterally plus one, GV-20).
After skin antisepsis, sterile acupuncture needles 
(0.25 mm × 25 mm) were inserted to depths of 0.5-
2.0 cm. The needles were stimulated manually until 
the appearance of De Qi, which is a needle sensa-
tion characterized by a subjective nonpainful symp-
tom, tingling or distention around the acupoint, or 
a radiating sensation originating from the needled 
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1 F 44 Unknown primary 7,000 + + + + + + - -
2 M 46 Larynx 7,580 + + + + + + + -
3 F 59 Oral cavity 6,600 + + + + + + + +
4 M 60 Oropharynx 6,040 + + + + + + - +
5 M 54 Oropharynx 7,000 ± + + ± + + + -
6 M 59 Nasopharynx 7,000 ± + + ± + + - -
7 M 61 Hypopharynx 6,040 + + + + + + + +
8 F 52 Oral cavity 6,440 + + + + + + - +
9 M 72 Larynx 7,100 ± + + ± + + - -
10 F 64 Unknown primary 7,040 + + + + + + + +
11 M 68 Oral cavity 7,000 + + + + + + + -
12 F 46 Unknown primary 7,040 + + + + + + + +
(+) salivary gland within the irradiation area; (-) salivary gland not irradiated; (±) salivary gland partially irradi-
ated; cGy = centiGray; CT = chemotherapy; SG = surgery.
Table 2 - Patient characteristics 
and treatment profiles in the 
CT group.
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1 F 50 Unknown primary 6,040 + + + + + + - +
2 M 59 Hypopharynx 7,040 + + + + + + + -
3 M 82 Hypopharynx 7,000 ± + + ± + + + -
4 F 69 Larynx 7,000 - + + - + + - -
5 M 54 Oral cavity 6,040 + + + + + + - +
6 M 67 Hypopharynx 7,040 ± + + ± + + - -
7 M 47 Larynx 6,040 ± + + ± + + - +
8 M 53 Larynx 7,500 + + + + + + + -
9 M 51 Oropharynx 6,040 + + + + + + - +
10 M 76 Larynx 7,000 + + + + + + - -
11 M 56 Larynx 6,040 ± + + ± + + + -
12 F 73 Oral cavity 6,040 + + + + + + - +
(+) salivary gland within the irradiation area; (-) salivary gland not irradiated; (±) salivary gland partially irradi-
ated; cGy = centiGray; CT = chemotherapy; SG = surgery.
Table 1 - Patient characteristics 
and treatment profiles in the 
PA group. 
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point. The needles were maintained in position for 
20  min and then removed. For auricular points, 
semipermanent needles (0.20 mm ×  1.5 mm) were 
inserted and maintained in position for 7 days with 
the aid of adhesive tape. After the auricular needles 
were removed, a new set was inserted, alternating 
each side weekly until the completion of RT.
Main outcome measures
The patient clinical response was assessed using 
objective (saliva collection) and subjective (xerosto-
mia questionnaire) methods to evaluate the salivary 
gland functions and xerostomia-related symptoms. 
In both the PA and CT groups, measurements for 
each patient were performed at the same time of day 
(2 to 4 pm) after RT completion.
Saliva collection
Saliva sampling was performed according to a 
standardized technique.20 For the resting salivary 
flow rate (RSFR), all saliva produced over 10  min 
was collected by spitting. For the stimulated salivary 
flow rate (SSFR), all saliva collected over 2 min with 
paraffin chewing was collected. RSFR and SSFR 
were determined volumetrically in mL/min. The ref-
erence values considered respectively for RSFR and 
SSFR were: 
•	normal flow (0.25-0.35; 1.0-3.0 mL/min), 
•	 low flow (0.10-0.25; 0.70-1.0 mL/min), and 
•	hyposalivation ( < 0.1; < 0.7 mL/min).
Xerostomia questionnaire
A modified visual analog scale (VAS; 0-100 mm) 
xerostomia questionnaire was administered to 
quantify the self-report of dry mouth symptoms. 
The questions addressed were: 
•	Q1, rate the difficulty you experience in speak-
ing due to dryness; 
•	Q2, rate the difficulty you experience in swal-
lowing due to dryness; 
•	Q3, rate how much saliva is in your mouth; 
•	Q4, rate the dryness of your mouth. 
For Q1, Q2, and Q4, higher scores represent a 
greater subjective degree of xerostomia; for Q3, 
higher scores represent greater saliva production.
Statistical analysis
Statistical analyses with a mixed model proce-
dure using random and fixed factors and analysis of 
variance (ANOVA) were performed to compare dif-
ferences between the PA and CT groups. An alpha 
level of 0.05 was accepted for a statistical signifi-
cance. Data obtained from these analyses were used 
to estimate the effectiveness of PA.
Results
Previous analyses were performed to investigate 
similarities between the PA and CT groups regard-
ing related factors that could influence acupunc-
ture analysis. No significant differences were found 
among the variables age, gender, RT planning, che-
motherapy, surgery, and their associations. Subse-
quently, data from the main outcomes measured in 
both groups after RT were compared.
The objective and subjective outcomes measured 
in the PA and CT groups are detailed in Table 3 
and illustrated in Figures 1 and 2. After RT, all pa-
tients exhibited some degree of impairment in their 
salivary gland functioning. Nevertheless, significant 
Main outcomes
PA Group - after RT  
mean (range)
CT Group - after RT 
mean (range)
p-value
RSFR (mL/min) 0.21 (0.01 - 0.56)  0.04  (0 - 0.16) p < 0.001
SSFR (mL/min) 0.49 (0.05 - 0.98)  0.12  (0 - 0.48) p < 0.001
VAS Q1 (0-100) 23.1 (0 - 53)  53.7 (7 - 96) p < 0.05
VAS Q2 (0-100) 30.3 (0 - 74)  71.1 (0 - 100) p < 0.05
VAS Q3 (0-100) 51.8 (9 - 75)  15.3 (0 - 66) p < 0.001
VAS Q4 (0-100) 39.8 (0 - 90)  74.6 (1 - 100) p < 0.05
Table 3 - Salivary flow rates 
and VAS results in the PA and CT 
groups.
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differences between the groups were demonstrated 
after RT completion for both objective (saliva col-
lection) and subjective (xerostomia questionnaire) 
main outcomes.
Data from sialometry revealed that patients in 
the PA group obtained higher mean RSFR and SSFR 
values than individuals in the CT group (p < 0.001). 
Similarly, the data obtained from the VAS ques-
tionnaires revealed that the means of the VAS 
scores were significantly lower for Q1, Q2, and Q4 
(p < 0.05) and higher for Q3 (p < 0.001) in the PA 
group than in the CT group.
In addition to the results described above, oth-
er subjective findings related to the alleviation of 
oral and systemic symptoms, including a reduction 
in burning and painful sensations, dysgeusia, and 
sleeping, also were observed. Acupuncture treat-
ment was well-tolerated by all patients. No severe 
adverse effects were evidenced, although somno-
lence and/or tiny hemorrhages at the puncture sites 
causing small hematomas were reported.
Discussion
In this study, we report an innovative protocol 
for xerostomia prevention through PA treatment, 
and evaluated its clinical effectiveness in minimiz-
ing the severity of irradiation side effects on salivary 
flow rates and xerostomia-related symptoms. Based 
on objective and subjective analyses, our clinical 
findings showed a significant maintenance of sali-
vary flow rates and oral functions (e.g., chewing, 
swallowing, and speech) for most patients who re-
ceived PA treatment as compared with those who 
did not receive acupuncture. The effective use of 
acupuncture is preferable to pharmacological agents 
(e.g., pilocarpine or amifostine) because acupunc-
ture presents virtually no significant side-effects. In 
addition, patient dropout, which is common in stud-
ies using pharmacological agents,6-10 was not seen 
in this study, showing the clinical feasibility of the 
therapy.
Among control groups employed in acupuncture 
clinical trials, superficial, placebo, or sham acu-
puncture methods are common. Studies have shown 
that even superficial needling is able to promote sen-
sory stimulation, although with a lower intensity 
than the standard needling technique.13,14 Therefore, 
we employed reference data measured after RT to 
compare differences between the PA and CT groups.
The specific mechanisms underlying the effects 
of acupuncture on salivary gland tissue are not well 
known. Further studies with a larger sample should 
be conducted to corroborate the effectiveness of PA 
treatment, as well as to investigate its mechanism of 
action.
Conclusion
Patients receiving PA exhibited significantly im-
proved salivary flow rates and decreased xerostomia-
related symptoms compared to patients who did not 
receive acupuncture. Although PA treatment did not 
prevent the oral sequelae of RT completely, it signifi-
cantly minimized the severity of radiation-induced 
xerostomia. These findings suggest that acupuncture 
Figure 1 - Mean values of RSFR and SSFR after RT in the 
PA and CT groups.
Figure 2 - Mean scores on the 4-item VAS xerostomia 
questionnaire after RT in the PA and CT groups.
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can be a useful therapy in the management of pa-
tients with head and neck cancer undergoing RT.
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